The evolution of pharmaceutical sciences has been propelled by innovative therapeutic strategies designed to enhance efficacy, safety, and patient-centric outcomes. Integrating nanomedicine, precision therapy, and bioengineering approaches has paved the way for highly sophisticated drug delivery systems capable of targeting diseased tissues with minimal systemic toxicity (Kumar et al., 2022; Zhang & Li, 2021). Nanoparticles, including liposomes, polymeric nanocarriers, dendrimers, and metallic nanostructures, have demonstrated enhanced bioavailability, controlled release, and improved pharmacokinetics for diverse drug classes (Patel et al., 2020). Precision therapy, guided by biomarkers and genetic profiling, allows for individualized treatment regimens that optimize therapeutic efficacy while reducing adverse effects (Chen et al., 2019). Concurrently, bioengineering strategies such as organ-on-chip models, 3D bioprinting, and tissue-engineered scaffolds have facilitated the development of predictive preclinical models and personalized drug testing platforms (Singh et al., 2021). This comprehensive review synthesizes recent advancements across these domains, critically evaluating technological innovations, clinical translational progress, and regulatory considerations. Furthermore, it identifies persistent challenges, including immunogenicity, stability, scalability, and ethical implications, while proposing integrative strategies for accelerating clinical adoption. The integration of these multi-disciplinary approaches represents a paradigm shift in pharmaceutical sciences, heralding a future where therapeutics are more precise, efficacious, and patient-tailored.

Nanomedicine, Precision Therapy, Drug Delivery Systems, Bioengineering, Personalized Medicine, Pharmacokinetics, Tissue Engineering

Chen, L., Wang, H., & Zhao, Y. (2019). Biomarker-guided precision pharmacotherapy in oncology. Journal of Translational Medicine, 17(1), 89.

Kumar, S., Patel, R., & Singh, A. (2022). Nanomedicine-based drug delivery systems: Advances and clinical translation. International Journal of Pharmaceutics, 612, 121456.

Patel, R., Sharma, D., & Verma, P. (2020). Polymeric nanoparticles for controlled drug delivery: Emerging trends and therapeutic applications. Pharmaceutical Research, 37(6), 1042–1061.

Ramesh, G., Gupta, N., & Verma, A. (2018). Nanotechnology in targeted drug delivery: Mechanisms, strategies, and challenges. Current Pharmaceutical Design, 24(42), 5002–5014.

Singh, A., Li, X., & Zhang, Y. (2021). Bioengineered tissue platforms for preclinical drug testing: Opportunities and limitations. Advanced Drug Delivery Reviews, 173, 135–152.

Zhang, Y., & Li, X. (2021). Integration of precision therapy and nanomedicine: Personalized approaches to modern therapeutics. ACS Applied Bio Materials, 4(12), 8912–8928.